MedPointe – Partnerships

There are many situations in which partnership can provide a compelling solution. Products that once were central now may seem marginal, overshadowed by more recent product launches. A merger might result in product redundancies – or require product divestiture in order to receive regulatory approval. A promising new therapy might need the benefit of a first-rate, experienced sales force to successfully compete in a crowded market.

MedPointe’s management team has an unmatched track record in creating win-win partnerships. The company is led by Tony Wild, who, as a top executive at Warner-Lambert, engineered many high-profile arrangements, including the Sankyo/Parke-Davis joint venture, the Lipitor® global partnership with Pfizer, and the acquisitions of Jouveinal, Agouron, Hickson and gene/Networks. Earlier, at Schering-Plough, Tony served as president of the firm’s Japanese operations, a $500 million business built on a complex web of licensee/licensor partnerships with major Japanese companies.

Partnering with MedPointe gives you access to the resources of an organization with proven strength in penetrating niche markets and building successful and long-lasting relationships with physicians and managed care organizations. MedPointe partnership possibilities include:

• Branded Product Acquisitions
• Joint Ventures
• Co-marketing and Co-promotion of Current and New Products
• Life Cycle Management
  • New Indications
  • Reformulations
  • Repackaging
  • New Delivery Mechanisms
• Targeted Promotions
• Licensing